Company: IONQ
Filing Date: 2025-09-18
Form Type: 8-K/A
Source: 0001193125-25-206731
Chunk: 1

Company: IonQ, Inc.
Filing Date: 2025-09-18
Form: 8-K/A
Chunk 1
---
 12b-2of the Securities Exchange Act of 1934 (§ 240.12b-2of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note This Amendment to the Current Report on Form 8-Kfiled with the SEC on September 17, 2025 (the “ Original 8-K”) is being filed solely to correct a typographical error in the Original 8-K.The Original 8-Kincorrectly stated that 26,622,077 shares of the common stock of the Company (as defined below) would be delivered at the closing of the Oxford Ionics Transaction (as defined below). The correct number is 25,372,150 shares of the common stock of the Company. No other changes have been made to the Original 8-K.

| Item 3.02 | Unregistered Sales of Equity Securities. |

The information set forth under Item 8.01 of this Current Report on Form 8-Kis incorporated by reference into this Item 3.02. The issuance and sale of shares of IonQ, Inc. (the “ Company”) common stock in connection with the Oxford Ionics Transaction (as defined below) was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”), and/or the private offering provision of Rule 506 of Regulation D and/or Regulation S promulgated under the Securities Act. The issuance and sale of shares of Company common stock in connection with the Vector Atomic Transaction (as defined below) will be made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act, and/or the private offering provision of Rule 506 of Regulation D and/or Regulation S promulgated under the Securities Act.

| Item 7.01 | Regulation FD Disclosure. |

On September 17, 2025, the Company issued a press release announcing the completion of the Oxford Ionics Transaction and a press release announcing the entry into the Vector Atomic Transaction. Copies of the press releases have been furnished as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-Kand are incorporated herein by reference. The information provided pursuant to